VALBIOTIS: Information on Share Capital in August 2025

On September 1, 2025, Valbiotis, a company listed on Euronext Growth Paris, announced key information regarding its share capital as of August 31, 2025. The share capital is composed of 23,698,234 shares. The total number of theoretical voting rights amounts to 24,402,952, with 24,364,450 exercisable voting rights, after deduction of treasury shares.

According to Article 10.5 of the company's bylaws, any crossing of the 5%, 10%, 15%, 20%, or 30% share capital thresholds must be reported to the company within four trading days. Failure to comply may result in voting rights being suspended for two years. This procedure aims to ensure transparency, which is essential for investors.